Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood 2018 Apr 05;131(14):1532-1544

Date

02/14/2018

Pubmed ID

29437554

Pubmed Central ID

PMC6027092

DOI

10.1182/blood-2017-05-783845

Scopus ID

2-s2.0-85047638589 (requires institutional sign-in at Scopus site)   35 Citations

Abstract

Chronic myeloid leukemia (CML) stem/progenitor cells (SPCs) express a transcriptional program characteristic of proliferation, yet can achieve and maintain quiescence. Understanding the mechanisms by which leukemic SPCs maintain quiescence will help to clarify how they persist during long-term targeted treatment. We have identified a novel BCR-ABL1 protein kinase-dependent pathway mediated by the upregulation of hsa-mir183, the downregulation of its direct target early growth response 1 (EGR1), and, as a consequence, upregulation of E2F1. We show here that inhibition of hsa-mir183 reduced proliferation and impaired colony formation of CML SPCs. Downstream of this, inhibition of E2F1 also reduced proliferation of CML SPCs, leading to p53-mediated apoptosis. In addition, we demonstrate that E2F1 plays a pivotal role in regulating CML SPC proliferation status. Thus, for the first time, we highlight the mechanism of hsa-mir183/EGR1-mediated E2F1 regulation and demonstrate this axis as a novel, critical factor for CML SPC survival, offering new insights into leukemic stem cell eradication.

Author List

Pellicano F, Park L, Hopcroft LEM, Shah MM, Jackson L, Scott MT, Clarke CJ, Sinclair A, Abraham SA, Hair A, Helgason GV, Aspinall-O'Dea M, Bhatia R, Leone G, Kranc KR, Whetton AD, Holyoake TL

Author

Gustavo Leone PhD Sr Associate Dean, Director, Professor in the Biochemistry department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Cell Proliferation
Cell Survival
E2F1 Transcription Factor
Early Growth Response Protein 1
Female
Gene Expression Regulation, Leukemic
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Mice, Knockout
MicroRNAs
Neoplasm Proteins
Neoplastic Stem Cells
RNA, Neoplasm
Signal Transduction
Up-Regulation